Article
OTAL media kit
Doheny Eye Institute ophthalmologists to present at the AAO 2024 Annual Meeting
Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus
Clearside Biomedical unveils positive topline results from ODYSSEY Phase 2b Trial of suprachoroidal CLS-AX in wet AMD
Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy
Eyes on the Prize: Winning Strategies to Help Your Practice Thrive
Researchers test scanning retina with AI to determine cardiovascular risk